Chongyi Li

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Ischemia Reperfusion Injury

Gold Nanoparticles

Reactive Oxygen Species

Top Venues

Pharmaceuticals (Basel, Switzerland)

Neurotoxicity research

This page only lists publications with an associated author ORCID identifier.

Publications

Qifang Chen, Peilin Gu, Xuemei Liu, Shaohua Hu, Hong Zheng, Ting Liu, Chongyi Li
Gold Nanoparticles Encapsulated Resveratrol as an Anti-Aging Agent to Delay Cataract Development. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Qifang Chen, Peilin Gu, Xuemei Liu, Shaohua Hu, Hong Zheng, Ting Liu, Chongyi Li
Gold Nanoparticles Encapsulated Resveratrol as an Anti-Aging Agent to Delay Cataract Development. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Qifang Chen, Peilin Gu, Xuemei Liu, Shaohua Hu, Hong Zheng, Ting Liu, Chongyi Li
Gold Nanoparticles Encapsulated Resveratrol as an Anti-Aging Agent to Delay Cataract Development. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Qifang Chen, Peilin Gu, Xuemei Liu, Shaohua Hu, Hong Zheng, Ting Liu, Chongyi Li
Gold Nanoparticles Encapsulated Resveratrol as an Anti-Aging Agent to Delay Cataract Development. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Chongyi Li, Zhao Geng, Bo Yang, He Xiao, Zhiqiang Wang, Jian Ye
Serum Aβ Levels are Associated with Age-related Cataract. Neurotoxicity research 39 (2) (2021)